Skip to content

Atrial Fibrillation at the Viennese University Emergency Department

Atrial Fibrillation Registry at the Emergency Department of the Medical University of Vienna: A Tool for Structured Diagnosis and Treatment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03272620
Enrollment
3000
Registered
2017-09-05
Start date
2014-10-22
Completion date
2030-01-01
Last updated
2017-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Atrial Flutter

Brief summary

The results of this study could imply that a atrial fibrillation registry, as a tool for structured diagnosis and therapy in patients with atrial fibrillation, may improve patient care for this rapidly growing population.

Detailed description

Atrial fibrillation is the most common cardiac arrhythmia and is associated with increased cardiovascular morbidity and mortality, with stroke being an especially important and potentially devastating complication. The number of patients with atrial fibrillation is likely to increase 2.5-fold during the next 50 years, reflecting the growing proportion of elderly individuals. Emergency departments play a central role in diagnosis and treatment (rhythm and rate control, initiation of anticoagulatory therapy for stroke prevention) of atrial fibrillation. Additionally, embolic (e.g. stroke, mesenteric ischemia) complications of atrial fibrillation and bleeding complications (e.g. gastrointestinal and intracranial) of anticoagulatory therapy are likewise treated at emergency departments. Therefor the investigators hypothesis implies that the atrial fibrillation registry could serve as a tool for structured diagnosis and therapy in patients with atrial fibrillation and therefore may improve patient care. Additionally, diagnostic and therapeutic shortcomings by analyzing registry data may be detected.

Interventions

None listed

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with atrial fibrillation treated at the Emergency Department of the Medical University of Vienna * Signed consent

Exclusion criteria

* Inclusion criteria not met

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with major adverse cardiac eventsFollow up (10 years)frequency distribution

Secondary

MeasureTime frameDescription
Number of successfully conducted cardioversionsFollow up (10 years)frequency distribution

Countries

Austria

Contacts

Primary ContactJan Niederdöckl, Dr.
jan.niederdöckl@meduniwien.ac.at
Backup ContactAlexander Simon, Dr.
alexander.simon@meduniwien.ac.at

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026